カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のベバシズマブ市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Bevacizumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19175）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19175
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のベバシズマブ市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ベバシズマブ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のベバシズマブの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ベバシズマブ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・アバスチン（ベバシズマブ）、ムバシ（ベバシズマブ-awwb）

用途別セグメントは次のように区分されます。
・がん、眼病

世界のベバシズマブ市場の主要な市場プレーヤーは以下のとおりです。
・Genentech、Amgen

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ベバシズマブ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なベバシズマブメーカーの企業概要、2019年～2022年までのベバシズマブの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なベバシズマブメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ベバシズマブの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのベバシズマブの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのベバシズマブ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびベバシズマブの産業チェーンを掲載しています。
・第13、14、15章では、ベバシズマブの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ベバシズマブの概要
- 種類別分析（2017年vs2021年vs2028年）：アバスチン（ベバシズマブ）、ムバシ（ベバシズマブ-awwb）
- 用途別分析（2017年vs2021年vs2028年）：がん、眼病
- 世界のベバシズマブ市場規模・予測
- 世界のベバシズマブ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Genentech、Amgen
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：アバスチン（ベバシズマブ）、ムバシ（ベバシズマブ-awwb）
・用途別分析2017年-2028年：がん、眼病
・ベバシズマブの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ベバシズマブのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ベバシズマブのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ベバシズマブの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ベバシズマブの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Bevacizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bevacizumab market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer accounting for % of the Bevacizumab global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Avastin (bevacizumab) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bevacizumab include Genentech, Amgen, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bevacizumab market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Avastin (bevacizumab)
Mvasi (bevacizumab-awwb)
Market segment by Application can be divided into
Cancer
Eye Diease
The key market players for global Bevacizumab market are listed below:
Genentech
Amgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bevacizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bevacizumab, with price, sales, revenue and global market share of Bevacizumab from 2019 to 2022.
Chapter 3, the Bevacizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bevacizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bevacizumab market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bevacizumab.
Chapter 13, 14, and 15, to describe Bevacizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Bevacizumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bevacizumab Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Avastin (bevacizumab)
1.2.3 Mvasi (bevacizumab-awwb)
1.3 Market Analysis by Application
1.3.1 Overview: Global Bevacizumab Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Eye Diease
1.4 Global Bevacizumab Market Size & Forecast
1.4.1 Global Bevacizumab Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bevacizumab Sales in Volume (2017-2028)
1.4.3 Global Bevacizumab Price (2017-2028)
1.5 Global Bevacizumab Production Capacity Analysis
1.5.1 Global Bevacizumab Total Production Capacity (2017-2028)
1.5.2 Global Bevacizumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bevacizumab Market Drivers
1.6.2 Bevacizumab Market Restraints
1.6.3 Bevacizumab Trends Analysis
2 Manufacturers Profiles
2.1 Genentech
2.1.1 Genentech Details
2.1.2 Genentech Major Business
2.1.3 Genentech Bevacizumab Product and Services
2.1.4 Genentech Bevacizumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Bevacizumab Product and Services
2.2.4 Amgen Bevacizumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bevacizumab Breakdown Data by Manufacturer
3.1 Global Bevacizumab Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bevacizumab Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bevacizumab
3.4 Market Concentration Rate
3.4.1 Top 3 Bevacizumab Manufacturer Market Share in 2021
3.4.2 Top 6 Bevacizumab Manufacturer Market Share in 2021
3.5 Global Bevacizumab Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bevacizumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bevacizumab Market Size by Region
4.1.1 Global Bevacizumab Sales in Volume by Region (2017-2028)
4.1.2 Global Bevacizumab Revenue by Region (2017-2028)
4.2 North America Bevacizumab Revenue (2017-2028)
4.3 Europe Bevacizumab Revenue (2017-2028)
4.4 Asia-Pacific Bevacizumab Revenue (2017-2028)
4.5 South America Bevacizumab Revenue (2017-2028)
4.6 Middle East and Africa Bevacizumab Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bevacizumab Sales in Volume by Type (2017-2028)
5.2 Global Bevacizumab Revenue by Type (2017-2028)
5.3 Global Bevacizumab Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bevacizumab Sales in Volume by Application (2017-2028)
6.2 Global Bevacizumab Revenue by Application (2017-2028)
6.3 Global Bevacizumab Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bevacizumab Sales by Type (2017-2028)
7.2 North America Bevacizumab Sales by Application (2017-2028)
7.3 North America Bevacizumab Market Size by Country
7.3.1 North America Bevacizumab Sales in Volume by Country (2017-2028)
7.3.2 North America Bevacizumab Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bevacizumab Sales by Type (2017-2028)
8.2 Europe Bevacizumab Sales by Application (2017-2028)
8.3 Europe Bevacizumab Market Size by Country
8.3.1 Europe Bevacizumab Sales in Volume by Country (2017-2028)
8.3.2 Europe Bevacizumab Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bevacizumab Sales by Type (2017-2028)
9.2 Asia-Pacific Bevacizumab Sales by Application (2017-2028)
9.3 Asia-Pacific Bevacizumab Market Size by Region
9.3.1 Asia-Pacific Bevacizumab Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bevacizumab Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bevacizumab Sales by Type (2017-2028)
10.2 South America Bevacizumab Sales by Application (2017-2028)
10.3 South America Bevacizumab Market Size by Country
10.3.1 South America Bevacizumab Sales in Volume by Country (2017-2028)
10.3.2 South America Bevacizumab Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bevacizumab Sales by Type (2017-2028)
11.2 Middle East & Africa Bevacizumab Sales by Application (2017-2028)
11.3 Middle East & Africa Bevacizumab Market Size by Country
11.3.1 Middle East & Africa Bevacizumab Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bevacizumab Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bevacizumab and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bevacizumab
12.3 Bevacizumab Production Process
12.4 Bevacizumab Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bevacizumab Typical Distributors
13.3 Bevacizumab Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Bevacizumab Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Bevacizumab Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Genentech Basic Information, Manufacturing Base and Competitors
Table 4. Genentech Major Business
Table 5. Genentech Bevacizumab Product and Services
Table 6. Genentech Bevacizumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Bevacizumab Product and Services
Table 10. Amgen Bevacizumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Bevacizumab Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Bevacizumab Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Bevacizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Bevacizumab Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Bevacizumab Production Site of Key Manufacturer
Table 16. Bevacizumab New Entrant and Capacity Expansion Plans
Table 17. Bevacizumab Mergers & Acquisitions in the Past Five Years
Table 18. Global Bevacizumab Sales by Region (2017-2022) & (K Units)
Table 19. Global Bevacizumab Sales by Region (2023-2028) & (K Units)
Table 20. Global Bevacizumab Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Bevacizumab Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 23. Global Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 24. Global Bevacizumab Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Bevacizumab Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Bevacizumab Price by Type (2017-2022) & (USD/Unit)
Table 27. Global Bevacizumab Price by Type (2023-2028) & (USD/Unit)
Table 28. Global Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 29. Global Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 30. Global Bevacizumab Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Bevacizumab Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Bevacizumab Price by Application (2017-2022) & (USD/Unit)
Table 33. Global Bevacizumab Price by Application (2023-2028) & (USD/Unit)
Table 34. North America Bevacizumab Sales by Country (2017-2022) & (K Units)
Table 35. North America Bevacizumab Sales by Country (2023-2028) & (K Units)
Table 36. North America Bevacizumab Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Bevacizumab Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 39. North America Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 40. North America Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 41. North America Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 42. Europe Bevacizumab Sales by Country (2017-2022) & (K Units)
Table 43. Europe Bevacizumab Sales by Country (2023-2028) & (K Units)
Table 44. Europe Bevacizumab Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Bevacizumab Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 47. Europe Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 48. Europe Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 49. Europe Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Bevacizumab Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Bevacizumab Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Bevacizumab Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Bevacizumab Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 58. South America Bevacizumab Sales by Country (2017-2022) & (K Units)
Table 59. South America Bevacizumab Sales by Country (2023-2028) & (K Units)
Table 60. South America Bevacizumab Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Bevacizumab Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 63. South America Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 64. South America Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 65. South America Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Bevacizumab Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Bevacizumab Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Bevacizumab Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Bevacizumab Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Bevacizumab Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Bevacizumab Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Bevacizumab Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Bevacizumab Sales by Application (2023-2028) & (K Units)
Table 74. Bevacizumab Raw Material
Table 75. Key Manufacturers of Bevacizumab Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Bevacizumab Typical Distributors
Table 79. Bevacizumab Typical Customers
List of Figures
Figure 1. Bevacizumab Picture
Figure 2. Global Bevacizumab Revenue Market Share by Type in 2021
Figure 3. Avastin (bevacizumab)
Figure 4. Mvasi (bevacizumab-awwb)
Figure 5. Global Bevacizumab Revenue Market Share by Application in 2021
Figure 6. Cancer
Figure 7. Eye Diease
Figure 8. Global Bevacizumab Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Bevacizumab Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Bevacizumab Sales (2017-2028) & (K Units)
Figure 11. Global Bevacizumab Price (2017-2028) & (USD/Unit)
Figure 12. Global Bevacizumab Production Capacity (2017-2028) & (K Units)
Figure 13. Global Bevacizumab Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Bevacizumab Market Drivers
Figure 15. Bevacizumab Market Restraints
Figure 16. Bevacizumab Market Trends
Figure 17. Global Bevacizumab Sales Market Share by Manufacturer in 2021
Figure 18. Global Bevacizumab Revenue Market Share by Manufacturer in 2021
Figure 19. Bevacizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Bevacizumab Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Bevacizumab Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Bevacizumab Sales Market Share by Region (2017-2028)
Figure 23. Global Bevacizumab Revenue Market Share by Region (2017-2028)
Figure 24. North America Bevacizumab Revenue (2017-2028) & (USD Million)
Figure 25. Europe Bevacizumab Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Bevacizumab Revenue (2017-2028) & (USD Million)
Figure 27. South America Bevacizumab Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Bevacizumab Revenue (2017-2028) & (USD Million)
Figure 29. Global Bevacizumab Sales Market Share by Type (2017-2028)
Figure 30. Global Bevacizumab Revenue Market Share by Type (2017-2028)
Figure 31. Global Bevacizumab Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Bevacizumab Sales Market Share by Application (2017-2028)
Figure 33. Global Bevacizumab Revenue Market Share by Application (2017-2028)
Figure 34. Global Bevacizumab Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Bevacizumab Sales Market Share by Type (2017-2028)
Figure 36. North America Bevacizumab Sales Market Share by Application (2017-2028)
Figure 37. North America Bevacizumab Sales Market Share by Country (2017-2028)
Figure 38. North America Bevacizumab Revenue Market Share by Country (2017-2028)
Figure 39. United States Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Bevacizumab Sales Market Share by Type (2017-2028)
Figure 43. Europe Bevacizumab Sales Market Share by Application (2017-2028)
Figure 44. Europe Bevacizumab Sales Market Share by Country (2017-2028)
Figure 45. Europe Bevacizumab Revenue Market Share by Country (2017-2028)
Figure 46. Germany Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Bevacizumab Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Bevacizumab Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Bevacizumab Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Bevacizumab Revenue Market Share by Region (2017-2028)
Figure 55. China Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Bevacizumab Sales Market Share by Type (2017-2028)
Figure 62. South America Bevacizumab Sales Market Share by Application (2017-2028)
Figure 63. South America Bevacizumab Sales Market Share by Country (2017-2028)
Figure 64. South America Bevacizumab Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Bevacizumab Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Bevacizumab Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Bevacizumab Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Bevacizumab Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Bevacizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Bevacizumab in 2021
Figure 76. Manufacturing Process Analysis of Bevacizumab
Figure 77. Bevacizumab Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の三次元電気生理ナビゲーションシステム市場2022年：市場規模予測（～2028年）
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 世界のハイブリッド手首固定器市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19175 )"世界のベバシズマブ市場2022年：市場規模予測（～2028年）" (英文：Global Bevacizumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。